Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Euroapi SAS (EAPI)
The Euroapi share price today is 1.47, view EPA EAPI stock exchange data. Track the latest Euroapi share price with real-time updates on EAPI stock performance including market cap, day range, 52-week range and dividend yield. Access EAPI charts, earnings dates and analyst estimates to support your investment decisions.
Paris
Currency in EUR
1.47
-0.04(-2.52%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.47
1.53
52 wk Range
1.22
3.57
EAPI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.471.53
52 wk Range
1.223.57
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EAPI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
2.00
Upside
+36.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Euroapi receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
0 Buy
2 Hold
3 Sell
Ratings:
5 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 2.00
(+36.05% Upside)
Earnings
Latest Release
03-03-2026
EPS / Forecast
-1.93 / --
Revenue / Forecast
438.1M / --
Compare EAPI to Peers and Sector
Metrics to compare | EAPI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEAPIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | 1.1x | −0.5x | |
PEG Ratio | 0.01 | 0.02 | 0.00 | |
Price/Book | 0.2x | 1.0x | 2.6x | |
Price / LTM Sales | 0.2x | 2.4x | 3.2x | |
Upside (Analyst Target) | 13.3% | 23.9% | 48.3% | |
Fair Value Upside | Unlock | 13.7% | 5.6% | Unlock |
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. The company has a strategic alliance with Abolis Biotechnologies SAS for the development of microbial strains for the synthesis of key intermediates and 20 active ingredients. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Euroapi (EAPI) Share Price Today?
The Euroapi share price today is 1.47.
What is the current Euroapi (EAPI) share price and day range?
As of 07-05-2026, the Euroapi share price is 1.47, with a previous close of 1.51. The share price has ranged from 1.47 to 1.53 today, while the 52-week range spans from 1.22 to 3.57.
What Is the Euroapi Market Cap?
As of today, Euroapi market cap is 143.73M.
What Is the Euroapi (EAPI) Share Price Target?
The average 12-month share price target for Euroapi is 2.00, with a high estimate of 2.9 and a low estimate of 1. 0 analysts recommend buying, while 3 suggest selling, with an overall rating of Sell and +36.05% Upside potential.
What Is Euroapi's Earnings Per Share (TTM)?
The Euroapi EPS (TTM) is -2.23.
From a Technical Analysis Perspective, Is EAPI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Euroapi Trade On?
Euroapi is listed and trades on the Paris Stock Exchange.
What Is the Stock Symbol for Euroapi?
The stock symbol for Euroapi is "EAPI."
How Many Times Has Euroapi Stock Split?
Euroapi has split 0 times.
How Many Employees Does Euroapi Have?
Euroapi has 2961 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.